Sharjah 24: As part of the University of Sharjah’s (UOS) ongoing commitment to advancing cutting-edge cancer research and supporting scientific initiatives that contribute to improved patient care and healthcare solutions, the University organised a symposium on cancer research, with a particular focus on the integration of genomics, artificial intelligence, and precision-targeted therapies in cancer diagnosis, prognosis, and therapeutics. The symposium was organised over two days by the Centre of Excellence for Cancer Research (CECR) under the Research Institute for Medical and Health Sciences (RIMHS) at the University, with the participation of researchers, computer scientists, clinicians, and students.
Prof. Maamar Bettayeb, Vice Chancellor for Research and Graduate Studies, noted that the symposium addresses a highly important topic, emphasising that cancer remains a major global challenge. He explained that recent advances in artificial intelligence and data analytics are creating new opportunities for progress, and integration of AI and data science has contributed to the development of diagnostic tools and the advancement of medical research, making cancer research one of the most promising scientific fields in the coming years. He further stressed the importance of strengthening collaboration among universities and multidisciplinary research teams, given the inherently interdisciplinary nature of cancer research.
Prof. Rifat Hamoudi, Acting Director of the Research Institute for Medical and Health Sciences, stated that the symposium brings together multidisciplinary research from the fields of engineering, medicine, pharmacology, and computer science to address key challenges in cancer research, with the participation of distinguished international speakers.
He added: “Cancer remains one of the most complex diseases, creating major challenges in early diagnosis and long-term treatment. Recent advances in artificial intelligence and advanced biological analysis technologies are opening new opportunities to better understand cancer, identify more accurate diagnostic indicators, and develop more effective treatment approaches. This symposium highlights how collaboration between different scientific disciplines can accelerate progress in cancer research and improve future healthcare outcomes.”
Prof. Riyad Bendardaf, Director of the Centre of Excellence for Cancer Research, stated that the aim of organising the symposium is to highlight emerging technologies, translational cancer research, biomarker discovery, personalised medicine approaches, and the role of artificial intelligence in improving cancer management and research outcomes. In addition to encourage interdisciplinary collaboration and promote scientific exchange among experts in the fields of oncology and biomedical sciences.
For an optimal experience, please
